Suppr超能文献

新兴黄病毒的持续威胁。

The continued threat of emerging flaviviruses.

机构信息

Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, the National Institutes of Health, Bethesda, MD, USA.

Departments of Medicine, Molecular Microbiology, Pathology & Immunology, Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

Nat Microbiol. 2020 Jun;5(6):796-812. doi: 10.1038/s41564-020-0714-0. Epub 2020 May 4.

Abstract

Flaviviruses are vector-borne RNA viruses that can emerge unexpectedly in human populations and cause a spectrum of potentially severe diseases including hepatitis, vascular shock syndrome, encephalitis, acute flaccid paralysis, congenital abnormalities and fetal death. This epidemiological pattern has occurred numerous times during the last 70 years, including epidemics of dengue virus and West Nile virus, and the most recent explosive epidemic of Zika virus in the Americas. Flaviviruses are now globally distributed and infect up to 400 million people annually. Of significant concern, outbreaks of other less well-characterized flaviviruses have been reported in humans and animals in different regions of the world. The potential for these viruses to sustain epidemic transmission among humans is poorly understood. In this Review, we discuss the basic biology of flaviviruses, their infectious cycles, the diseases they cause and underlying host immune responses to infection. We describe flaviviruses that represent an established ongoing threat to global health and those that have recently emerged in new populations to cause significant disease. We also provide examples of lesser-known flaviviruses that circulate in restricted areas of the world but have the potential to emerge more broadly in human populations. Finally, we discuss how an understanding of the epidemiology, biology, structure and immunity of flaviviruses can inform the rapid development of countermeasures to treat or prevent human infections as they emerge.

摘要

黄病毒是经媒介传播的 RNA 病毒,可在人群中意外出现并引发一系列潜在严重疾病,包括肝炎、血管休克综合征、脑炎、急性弛缓性麻痹、先天畸形和胎儿死亡。在过去的 70 年中,这种流行病学模式已经多次出现,包括登革热病毒和西尼罗河病毒的流行,以及最近美洲发生的寨卡病毒爆炸性流行。黄病毒现在在全球范围内传播,每年感染多达 4 亿人。值得关注的是,在世界不同地区的人类和动物中报告了其他一些特征不那么明显的黄病毒的暴发。这些病毒在人类中维持流行传播的潜力尚未得到充分了解。在这篇综述中,我们讨论了黄病毒的基本生物学、它们的感染周期、它们引起的疾病以及宿主对感染的潜在免疫反应。我们描述了那些对全球健康构成持续威胁的黄病毒,以及那些最近在新人群中出现并导致严重疾病的黄病毒。我们还提供了在世界某些地区传播但有可能在人类中更广泛传播的鲜为人知的黄病毒的例子。最后,我们讨论了如何理解黄病毒的流行病学、生物学、结构和免疫,以便在出现时迅速开发出治疗或预防人类感染的对策。

相似文献

1
The continued threat of emerging flaviviruses.
Nat Microbiol. 2020 Jun;5(6):796-812. doi: 10.1038/s41564-020-0714-0. Epub 2020 May 4.
2
A review of West Nile and Usutu virus co-circulation in Europe: how much do transmission cycles overlap?
Trans R Soc Trop Med Hyg. 2015 Oct;109(10):609-18. doi: 10.1093/trstmh/trv066. Epub 2015 Aug 17.
3
INFECTIOUS DISEASES. An obscure mosquito-borne disease goes global.
Science. 2015 Nov 27;350(6264):1012-3. doi: 10.1126/science.350.6264.1012.
4
Anticipating Emerging Mosquito-borne Flaviviruses in the USA: What Comes after Zika?
Trends Parasitol. 2018 Jul;34(7):544-547. doi: 10.1016/j.pt.2018.02.010. Epub 2018 Mar 15.
5
The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses.
Zoonoses Public Health. 2009 Aug;56(6-7):338-56. doi: 10.1111/j.1863-2378.2008.01208.x.
7
Neuroinvasive flavivirus infections.
Rev Med Virol. 2012 Mar;22(2):69-87. doi: 10.1002/rmv.712. Epub 2011 Nov 16.
8
Historical Perspectives on Flavivirus Research.
Viruses. 2017 Apr 30;9(5):97. doi: 10.3390/v9050097.
9
The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.01970-16. Print 2017 Feb 1.

引用本文的文献

2
Seroprevalence of West Nile Virus in Blood Donors in Mainland Portugal.
Trop Med Infect Dis. 2025 Aug 15;10(8):229. doi: 10.3390/tropicalmed10080229.
3
Human T Cell Responses to Flavivirus Vaccines.
Eur J Immunol. 2025 Aug;55(8):e70027. doi: 10.1002/eji.70027.
4
Vector competence of European mosquito species for Japanese encephalitis virus under fluctuating temperature conditions.
Curr Res Parasitol Vector Borne Dis. 2025 Jul 31;8:100302. doi: 10.1016/j.crpvbd.2025.100302. eCollection 2025.
6
Irreversible furin cleavage site exposure renders immature tick-borne flaviviruses fully infectious.
Nat Commun. 2025 Aug 12;16(1):7491. doi: 10.1038/s41467-025-62750-6.
7
Dissecting the host determinants of flavivirus infection using QIC-seq.
bioRxiv. 2025 Jul 15:2025.07.15.664960. doi: 10.1101/2025.07.15.664960.
8
Factors determining the outcomes of immune imprinting after repeated orthoflavivirus infections.
Front Immunol. 2025 Jul 16;16:1560851. doi: 10.3389/fimmu.2025.1560851. eCollection 2025.
9
Innate Immune Response to Powassan Virus Infection: Progress Toward Infection Control.
Vaccines (Basel). 2025 Jul 15;13(7):754. doi: 10.3390/vaccines13070754.

本文引用的文献

1
Integrin αvβ5 Internalizes Zika Virus during Neural Stem Cells Infection and Provides a Promising Target for Antiviral Therapy.
Cell Rep. 2020 Jan 28;30(4):969-983.e4. doi: 10.1016/j.celrep.2019.11.020. Epub 2020 Jan 16.
2
Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αβ Axis.
Cell Stem Cell. 2020 Feb 6;26(2):187-204.e10. doi: 10.1016/j.stem.2019.11.016. Epub 2020 Jan 16.
3
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
N Engl J Med. 2019 Nov 21;381(21):2009-2019. doi: 10.1056/NEJMoa1903869. Epub 2019 Nov 6.
4
Mechanisms of Pathogen Invasion into the Central Nervous System.
Neuron. 2019 Sep 4;103(5):771-783. doi: 10.1016/j.neuron.2019.07.015.
5
STING is required for host defense against neuropathological West Nile virus infection.
PLoS Pathog. 2019 Aug 15;15(8):e1007899. doi: 10.1371/journal.ppat.1007899. eCollection 2019 Aug.
7
Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques.
PLoS Pathog. 2019 Aug 1;15(8):e1007766. doi: 10.1371/journal.ppat.1007766. eCollection 2019 Aug.
8
Interferon-Stimulated Genes: What Do They All Do?
Annu Rev Virol. 2019 Sep 29;6(1):567-584. doi: 10.1146/annurev-virology-092818-015756. Epub 2019 Jul 5.
10
Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
Biochimie. 2019 Nov;166:132-141. doi: 10.1016/j.biochi.2019.05.004. Epub 2019 May 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验